NSE – NIFTY 750 | Lupin | 13 Mar 2026

Disclaimer

This analysis is part of a long-term structural study of ~750 stocks representing a large portion (~70–75%) of the Indian equity market. The objective is structural observation of long-term price behaviour rather than trading advice.

---

Structural Classification

Regime Shift Structure

---

Structural Interpretation

Lupin experienced a long secular advance from the early 2000s through the mid-2010s, during which price expanded steadily as the company established itself among India’s major pharmaceutical exporters. This period represented a strong upward structural regime.

Around 2015, the stock entered a prolonged distribution and decline phase. Regulatory challenges, sector-wide pressures, and earnings adjustments contributed to a structural breakdown that reversed the earlier expansion and resulted in several years of downward and sideways price behaviour.

Following this decline, price began stabilizing around the 2020 period and gradually transitioned into a recovery phase. The current structure appears to represent structural repair, with price rebuilding within a new regime rather than simply returning to the earlier secular advance.

---

Structural Observation

Secular Advance → Structural Distribution → Structural Decline → Structural Repair

---

Project Context

This chart forms part of the NIFTY 750 Structural Study, a long-term effort to observe structural behaviour across approximately 750 stocks representing a large portion of the Indian equity market.

The objective is to document structural regimes rather than produce trading signals.

---

Structure → Level → Trigger → Probability 

https://www.tradingview.com/chart/LUPIN/3SRVS633-NSE-NIFTY-750-Lupin-13-Mar-2026/

#NIFTY750
#Lupin
#MarketStructure
#ElliottWave
#PriceAction
#IndianStockMarket
#EwavesJournal